Laddar...
Clinical Effects of Topiroxostat on Renal and Endothelial Function in A Patient with Chronic Kidney Disease and Hyperuricemic Arteriolopathy: A Case Report
Hyperuricemia is associated with the progression of chronic kidney disease (CKD) and cardiovascular diseases. Topiroxostat, a selective xanthine oxidase inhibitor, effectively reduces serum uric acid (UA) levels and urinary albumin excretion (UAE) in CKD patients. A 50-year-old Japanese man was refe...
Sparad:
I publikationen: | Drugs R D |
---|---|
Huvudupphovsmän: | , , , |
Materialtyp: | Artigo |
Språk: | Inglês |
Publicerad: |
Springer International Publishing
2017
|
Ämnen: | |
Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5318337/ https://ncbi.nlm.nih.gov/pubmed/28074335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-016-0169-1 |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|